两种风险模型在预测冠状动脉计算机断层扫描血管造影术和经皮冠状动脉介入治疗后造影剂诱发肾病方面的比较

Valentin Trevizani Neto, Layla Lott, Davi Rios, Priscila Lima, Mário Bazzarella, Izabela Muniz, Sabrina Pereira, Vitor Rolim, Renato Serpa, O. Calil, Luiz Barbosa, Roberto Babosa
{"title":"两种风险模型在预测冠状动脉计算机断层扫描血管造影术和经皮冠状动脉介入治疗后造影剂诱发肾病方面的比较","authors":"Valentin Trevizani Neto, Layla Lott, Davi Rios, Priscila Lima, Mário Bazzarella, Izabela Muniz, Sabrina Pereira, Vitor Rolim, Renato Serpa, O. Calil, Luiz Barbosa, Roberto Babosa","doi":"10.31160/jotci202331a20230011","DOIUrl":null,"url":null,"abstract":"Background Contrast-induced nephropathy is one of the main causes of hospital-acquired acute renal failure. The Mehran risk score and the contrast medium volume used/creatinine clearance ratio could help identifying patients at higher risk of developing contrast-induced nephropathy. This study aimed to compare these two scores. Methods A retrospective, single-center observational study including hospitalized patients with baseline creatinine >1.3mg/dL, under observation for at least 48 hours after coronary computed tomography angiography and/or percutaneous coronary intervention. Mehran risk score and contrast medium volume used/creatinine clearance ratio were calculated for all patients, and the incidence of contrast-induced nephropathy was analyzed according to different cutoff points of both scores. Receiver Operating Characteristic curves were plotted to determine the accuracy of the methods in predicting contrast-induced nephropathy. The effectiveness of both methods was analyzed using Pearson’s correlation test. Results We included 102 patients and the incidence of contrast-induced nephropathy was 27.4%. The outcome occurred in 24.7% of patients when Mehran risk score ≥6, in 32.7% when Mehran risk score ≥10, and in 57.8% when Mehran risk score ≥15, in 28.7% of patients with contrast medium volume used/creatinine clearance ratio ≥2, 29.8% with contrast medium volume used/creatinine clearance ratio ≥3, and 34.3% with contrast medium volume used/creatinine clearance ratio ≥5. Receiver Operating Characteristic curves demonstrated area under the curve with moderate predictive capacity for Mehran risk score (0.7), and reduced/borderline for contrast medium volume used/creatinine clearance ratio (0.6). The correlation between the two scores was moderate. Conclusion Mehran risk score demonstrated greater accuracy in predicting contrast-induced nephropathy when compared to contrast medium volume used/creatinine clearance ratio, however both presented similar values. The cutoff points with the closest incidence between the two scores were ≥10 for Mehran risk score (32.7%) and ≥5 for volume used/creatinine clearance ratio (34.3%).","PeriodicalId":152272,"journal":{"name":"Journal of Transcatheter Interventions","volume":"51 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of two risk models in predicting contrast-induced nephropathy after coronary computed tomography angiography and percutaneous coronary intervention\",\"authors\":\"Valentin Trevizani Neto, Layla Lott, Davi Rios, Priscila Lima, Mário Bazzarella, Izabela Muniz, Sabrina Pereira, Vitor Rolim, Renato Serpa, O. Calil, Luiz Barbosa, Roberto Babosa\",\"doi\":\"10.31160/jotci202331a20230011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background Contrast-induced nephropathy is one of the main causes of hospital-acquired acute renal failure. The Mehran risk score and the contrast medium volume used/creatinine clearance ratio could help identifying patients at higher risk of developing contrast-induced nephropathy. This study aimed to compare these two scores. Methods A retrospective, single-center observational study including hospitalized patients with baseline creatinine >1.3mg/dL, under observation for at least 48 hours after coronary computed tomography angiography and/or percutaneous coronary intervention. Mehran risk score and contrast medium volume used/creatinine clearance ratio were calculated for all patients, and the incidence of contrast-induced nephropathy was analyzed according to different cutoff points of both scores. Receiver Operating Characteristic curves were plotted to determine the accuracy of the methods in predicting contrast-induced nephropathy. The effectiveness of both methods was analyzed using Pearson’s correlation test. Results We included 102 patients and the incidence of contrast-induced nephropathy was 27.4%. The outcome occurred in 24.7% of patients when Mehran risk score ≥6, in 32.7% when Mehran risk score ≥10, and in 57.8% when Mehran risk score ≥15, in 28.7% of patients with contrast medium volume used/creatinine clearance ratio ≥2, 29.8% with contrast medium volume used/creatinine clearance ratio ≥3, and 34.3% with contrast medium volume used/creatinine clearance ratio ≥5. Receiver Operating Characteristic curves demonstrated area under the curve with moderate predictive capacity for Mehran risk score (0.7), and reduced/borderline for contrast medium volume used/creatinine clearance ratio (0.6). The correlation between the two scores was moderate. Conclusion Mehran risk score demonstrated greater accuracy in predicting contrast-induced nephropathy when compared to contrast medium volume used/creatinine clearance ratio, however both presented similar values. The cutoff points with the closest incidence between the two scores were ≥10 for Mehran risk score (32.7%) and ≥5 for volume used/creatinine clearance ratio (34.3%).\",\"PeriodicalId\":152272,\"journal\":{\"name\":\"Journal of Transcatheter Interventions\",\"volume\":\"51 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Transcatheter Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31160/jotci202331a20230011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Transcatheter Interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31160/jotci202331a20230011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景造影剂诱发肾病是医院获得性急性肾功能衰竭的主要原因之一。Mehran 风险评分和造影剂使用量/肌酐清除率比值有助于识别造影剂诱发肾病风险较高的患者。本研究旨在比较这两种评分。方法 这是一项回顾性单中心观察研究,研究对象包括基线肌酐大于 1.3 毫克/分升、接受冠状动脉计算机断层扫描血管造影术和/或经皮冠状动脉介入治疗后观察至少 48 小时的住院患者。计算所有患者的 Mehran 风险评分和造影剂使用量/肌酐清除率,并根据这两个评分的不同临界点分析造影剂诱发肾病的发生率。绘制了接收者操作特征曲线,以确定这两种方法在预测造影剂诱发肾病方面的准确性。使用皮尔逊相关检验分析两种方法的有效性。结果 我们纳入了 102 名患者,对比剂诱发肾病的发生率为 27.4%。造影剂使用量/肌酐清除率比值≥2的患者占28.7%,造影剂使用量/肌酐清除率比值≥3的患者占29.8%,造影剂使用量/肌酐清除率比值≥5的患者占34.3%。接收者操作特征曲线显示,梅赫兰风险评分的曲线下面积具有中等预测能力(0.7),造影剂使用量/肌酐清除率的曲线下面积降低/边缘(0.6)。两个评分之间的相关性为中等。结论 与造影剂用量/肌酐清除率相比,梅兰风险评分在预测造影剂诱发肾病方面表现出更高的准确性,但两者的数值相似。两种评分之间发生率最接近的临界点分别是:Mehran 风险评分≥10(32.7%),造影剂使用量/肌酐清除率≥5(34.3%)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparison of two risk models in predicting contrast-induced nephropathy after coronary computed tomography angiography and percutaneous coronary intervention
Background Contrast-induced nephropathy is one of the main causes of hospital-acquired acute renal failure. The Mehran risk score and the contrast medium volume used/creatinine clearance ratio could help identifying patients at higher risk of developing contrast-induced nephropathy. This study aimed to compare these two scores. Methods A retrospective, single-center observational study including hospitalized patients with baseline creatinine >1.3mg/dL, under observation for at least 48 hours after coronary computed tomography angiography and/or percutaneous coronary intervention. Mehran risk score and contrast medium volume used/creatinine clearance ratio were calculated for all patients, and the incidence of contrast-induced nephropathy was analyzed according to different cutoff points of both scores. Receiver Operating Characteristic curves were plotted to determine the accuracy of the methods in predicting contrast-induced nephropathy. The effectiveness of both methods was analyzed using Pearson’s correlation test. Results We included 102 patients and the incidence of contrast-induced nephropathy was 27.4%. The outcome occurred in 24.7% of patients when Mehran risk score ≥6, in 32.7% when Mehran risk score ≥10, and in 57.8% when Mehran risk score ≥15, in 28.7% of patients with contrast medium volume used/creatinine clearance ratio ≥2, 29.8% with contrast medium volume used/creatinine clearance ratio ≥3, and 34.3% with contrast medium volume used/creatinine clearance ratio ≥5. Receiver Operating Characteristic curves demonstrated area under the curve with moderate predictive capacity for Mehran risk score (0.7), and reduced/borderline for contrast medium volume used/creatinine clearance ratio (0.6). The correlation between the two scores was moderate. Conclusion Mehran risk score demonstrated greater accuracy in predicting contrast-induced nephropathy when compared to contrast medium volume used/creatinine clearance ratio, however both presented similar values. The cutoff points with the closest incidence between the two scores were ≥10 for Mehran risk score (32.7%) and ≥5 for volume used/creatinine clearance ratio (34.3%).
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信